
This indispensable personal protective equipment did come up in short supply and reuse strategies has become a topic of great interest and research.
This indispensable personal protective equipment did come up in short supply and reuse strategies has become a topic of great interest and research.
The government-funded trial will seek to interpret the virus' transmissibility and infection, in order to inform vaccination and treatment strategies.
Study pinpoints the protein RIPK1 as a promising target for SARS-CoV-2 treatment.
The study was the first randomized clinical trial using the therapy to treat POTS.
As more people contract and recover from COVID-19, a small percentage suffer from lingering or even new symptoms for months. Post COVID clinics aim to address the causes and provide relief.
This new variant, B.1.525, was discovered in both the United Kingdom and Nigeria, and is now in 11 other countries including the United States.
Evaluating the impact of the SARS-CoV-2 virus on hospitalized patients.
The PCR diagnostic joins the company’s host of other SARS-CoV-2 research solutions.
Clostridioides difficile thrives in an environment of inflammation which found that inflammation provides nutrients for C. diff and creates an inhospitable environment for competing bacteria.
In an effort to understand the potential burden of asymptomatic SARS-Cov-2 infections in a traveling population, a group of investigators studied those entering China.
In this era of increasingly mobile and connected populations, it is possible for an infection to spread around the world in 24 to 48 hours.
Investigators said their paper was the first systematic review and meta-analysis of C diff infection diagnostic methods in Korea.
The World Health Organization (WHO) listed the vaccine for emergency use to enable countries who do not have vaccine agreements in place to work towards vaccinating their populations.
Preprint data show a US-based variant has come to represent more than 27% and 11% of all sequenced genomes in Louisiana and New Mexico, respectively, through mid-January.
CalciMedica has developed Auxora, a calcium release-activated calcium (CRAC) channel inhibitor, and it has shown it can reduce the levels of D-dimer, a key biomarker associated with COVID-19 mortality.
Case numbers trend downward in Germany as UK implements new border policies.
A new study suggests nursing homes with more people of color are actually at three-fold greater risk of COVID-19 mortality.
This technology is effective in cases that are difficult to diagnose.
New South Africa-based data show not only lessened protection versus the region's dominant variant, but a reduced vaccine-induced antibody neutralization.
Detailed analysis of SARS-CoV-2 showed predominant infection of human lung epithelial cells.
The study used electronic health record data and took account of a range of potentially influential factors.
Vaccination potential will not be achieved without a successful rollout plan.
CDC director says this is not mandatory, but is a road map and provides strategies for schools to reopen safely.
Decision comes as Biden states all Americans won’t be vaccinated by the end of summer.
Just months removed after its last outbreak, the country is seeing the emergence of another outbreak.
New CDC guidance highlights the importance of shingles vaccine, yet numbers suggest demand for it may be on decline.
Do people of varying age groups look at wearing a face mask differently?
Proper assessment of the severity and extent of pulmonary involvement is of paramount importance.